Health in Paraguay 1,304 indicators covering health for Paraguay. IndicatorLatest Year10-yr change Rank People practicing open defecation, urban (% of urban population): Q5 0.0% 2017 — 42nd Antenatal care attendees positive for syphilis who received treatment 65.9% 2023 up 8.2% 67th Hpv vaccination coverage in 15 year olds 83 2024 down 15.3% 20th Prevalence of syphilis 2.3% 2021 down 31.2% 19th UHC Service Coverage sub-index on infectious diseases - SDG 3.8.1 95 2023 up 11.8% 8th UHC Service Coverage sub-index on reproductive, maternal, newborn and 84 2023 unchanged 5th UHC Service Coverage sub-index on noncommunicable diseases - SDG 3.8.1 70 2023 up 7.7% 13th UHC Service Coverage Index - SDG 3.8.1 79 2023 up 14.5% 13th Maternal mortality ratio - SDG 3.1.1 58.27 2023 down 30.3% 14th UHC Service Coverage sub-index on service capacity and access - SDG 71 2023 up 42.0% 19th Sales of beer in 1000s hectolitres 2.46 2009 up 26.0% 140th Confirmed cases of MDR-TB 7 2012 down 46.2% 96th Current health expenditure 8.36 2023 up 37.8% 7th Domestic general government health expenditure 21.57 2023 up 42.4% 2nd Domestic general government health expenditure as % of GDP 4.63 2023 up 74.6% 11th Domestic general government health expenditure 55.42 2023 up 26.7% 19th Domestic general government health expenditure per capita in US$ 291.79 2023 up 70.3% 22nd New cases: other 187 2012 up 3,016.7% 9th Compliance with international health regulations 79 2016 down 4.8% 67th Number of disruptions to health services attributed to disasters 2 2023 — 25th Number of indigenous P. vivax malaria cases 0 2024 — 39th Number of imported malaria cases 2 2024 down 75.0% 53rd 1.1.1 Children living in households in extreme poverty 1.1 2022 down 79.6% 26th Out-of-school rate for children one year younger than the official 23.34 2023 up 61.3% 9th Number of out-of-school children one year younger than the official 31,830 2023 up 82.3% 6th Number of imported cases of cutaneous leishmaniasis reported 1 2024 down 75.0% 25th Number of imported cases of visceral leishmaniasis reported 0 2021 — 22nd Number of destroyed or damaged health facilities attributed to 2 2023 — 23rd Primary health care expenditure (PHCE) per сapita in US$ 257.64 2023 up 47.0% 38th Average cost of tuberculosis treatment by type 94 2024 up 168.6% 4th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 60.0% 2014 — 73rd Commitments to recipient countries 20.12 2010 up 234.2% 87th Disbursements to recipient countries 23.83 2010 up 127.0% 85th Imports in 1000s hectolitres 240 2005 down 22.1% 32nd Number of isolates tested for ceftriaxone 84 2020 up 546.2% 35th Proportion of isolates with decreased susceptibility or resistance 0 2020 — 13th Domestic general government expenditure on PHC as % of primary health 60.7% 2023 up 41.8% 2nd Proportion of isolates with resistance to ciprofloxacin reported to 72.2 2018 up 134.7% 20th Number of isolates tested for ciprofloxacin 36 2018 up 176.9% 42nd Proportion of isolates with decreased susceptibility or resistance 0 2018 — 25th Number of isolates tested for extended-spectrum cephalosporins 36 2018 up 1,100.0% 40th Civil registration coverage of cause-of-death 81.5% 2012 up 5.3% 50th Confirmed cases of MDR-TB started treatment for MDR-TB 86.0% 2012 — 29th Sales of wine in 1000s hectolitres 429 2007 up 68.9% 10th ← Previous Page 22 of 22